Coronil
- February 20, 2021
- Posted by: OptimizeIAS Team
- Category: DPN Topics
No Comments
Coronil
Subject: Science and Technology
Context: Coronil has received AYUSH certification as “Supportive measure for Covid-19.
Concept:
- According to the firm PatanjaliDivya, the coronil has certification from AYUSH Ministry as per WHO norms as a drug that can be used as “supporting measure in Covid-19” and as an immuno-booster.
- The firm said it received Certificate of Pharmaceutical Product (CoPP) from the Ayush section of Central Drugs Standard Control Organisation as per the WHO certification scheme.
- Last year the AYUSH Ministry banned Patanjali from selling Coronil tablet when it projected it as a “cure” and sought information on its trials.
About CoPP
- It is a WHO recommended certificate. The format is as per WHO guidelines and uniform across the world.
- It is mandatory to submit it to the importing country when the product is intended for licensing authorization or renewal of registration.
- It is recommended by WHO to facilitate the importing countries in assessing the quality of pharma products. Also, it is a prerequisite of importation and registration.
- CDSCO (It is India’s national regulatory body for pharmaceuticals and medical devices under the Ministry of Health) officers check and scrutinize the application and implement WHO standards.